Altman Advisors, Inc. Abb Vie Inc. Transaction History

Altman Advisors, Inc.

$204 Million
Q1 2024

A detailed history of Altman Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Altman Advisors, Inc. holds 11,291 shares of ABBV stock, worth $1.95 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

11,291

Previous 11,508 1.89%

Holding current value

$1.95 Million

Previous $1.78 Million 15.31%

% of portfolio

1.01%

Previous 0.94%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $34,680 - $39,515	-217 Reduced 1.89%	11,291 $2.06 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $21,052 - $23,710	153 Added 1.35%	11,508 $1.78 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $5,210 - $6,031	-39 Reduced 0.34%	11,355 $1.69 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $1.33 Million - $1.54 Million	-9,226 Reduced 44.74%	11,394 $1.82 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $483,116 - $579,383	-3,493 Reduced 14.49%	20,620 $3.33 Million

Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $85,223 - $97,745	-635 Reduced 2.57%	24,113 $3.24 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $208,494 - $265,064	-1,515 Reduced 5.77%	24,748 $3.47 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $57,807 - $71,722	-438 Reduced 1.64%	26,263 $4.26 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $108,182 - $136,881	1,007 Added 3.92%	26,701 $3.52 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $6,064 - $6,884	57 Added 0.22%	25,694 $2.95 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $75,014 - $83,570	713 Added 2.86%	25,637 $2.92 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $95,343 - $104,961	-932 Reduced 3.6%	24,924 $2.7 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $15,454 - $20,864	-192 Reduced 0.74%	25,856 $2.77 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $34,020 - $39,928	396 Added 1.54%	26,048 $2.28 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $49,671 - $66,467	-677 Reduced 2.57%	25,652 $2.52 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $93,267 - $141,404	-1,446 Reduced 5.21%	26,329 $2.01 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $84,897 - $106,224	-1,177 Reduced 4.07%	27,775 $2.46 Million
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $30,986 - $37,254	492 Added 1.73%	28,952 $2.19 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $58,735 - $75,078	894 Added 3.24%	28,460 $2.07 Million
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $55,077 - $64,824	714 Added 2.66%	27,566 $2.22 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $260,330 - $321,057	-3,344 Reduced 11.07%	26,852 $2.48 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $2.68 Million - $2.98 Million	30,196 New	30,196 $2.86 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $1.83 Million - $2.17 Million	-20,412 Closed	0 $0
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $1.48 Million - $1.99 Million	16,114 Added 374.92%	20,412 $1.93 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $384,928 - $422,106	4,298	4,298 $416,000

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.

Account

Altman Advisors, Inc. Abb Vie Inc. Transaction History